Larvol Delta - Biodexa-Completes-Recruitment-of-Cohort-A-in-Study-of-MTX110-in-Patients-with-Recurrent-Glioblastoma

panobinostat (MTX110) - Biodexa Pharma

https://www.globenewswire.com/news-release/2023/10/03/2753619/0/en/Biodexa-Completes-Recruitment-of-Cohort-A-in-Study-of-MTX110-in-Patients-with-Recurrent-Glioblastoma.html

Oct 3, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next